Remimazolam and Endovascular Procedures of Cerebrovascular Diseases
Launched by AIR FORCE MILITARY MEDICAL UNIVERSITY, CHINA · Jun 27, 2021
Trial Information
Current as of July 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. aged 18 years or older
- • 2. scheduled for interventional neurosurgery of cerebrovascular disorders under general anesthesia
- Exclusion Criteria:
- • 1. American Society of Anesthesiologists class Ⅲ or higher
- • 2. Hunt-Hess class Ⅲ or higher
- • 3. body mass index (BMI) \< 18 kg/㎡ or \> 30kg/㎡
- • 4. large or giant cerebral aneurysms with diameters greater than 15mm and minor cerebral aneurysms with diameters less than 3mm
- • 5. posterior circulation infarction
- • 6. recurrence of an cerebral aneurysms after endovascular procedures or surgical clipping
- • 7. severe abnormal coagulation function, severe liver and kidney function damage, or combined with heart and respiratory system failure
- • 8. be allergic or likely to be allergic to the study drugs
- • 9. participate in other clinical researchers within 3 months
- • 10. history of neurological or psychiatric diseases
- • 11. existed or suspected abuse of drug or alcohol
- • 12. use of sedative or analgesics before surgery
- • 13. patients with difficulty in communication
About Air Force Military Medical University, China
The Air Force Military Medical University (AFMMU) in China is a prestigious institution dedicated to advancing military medicine and healthcare research. With a strong emphasis on clinical trials and innovative medical practices, AFMMU integrates cutting-edge scientific research with practical applications to enhance the health and well-being of military personnel and the broader community. The university fosters collaboration among various disciplines, promoting a robust environment for training healthcare professionals and conducting impactful studies that address critical health challenges. Through its commitment to excellence and rigorous scientific methodology, AFMMU plays a pivotal role in shaping the future of military and civilian healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials